Penbutolol Sulfate

Penbutolol Sulfate (CAS No.: 38363-32-5) is a synthetic small molecule beta adrenergic receptor antagonist broadly categorized as a non selective beta blocker and commonly used in biomedical research as a pharmacological probe for sympathetic signaling and receptor cross talk, with additional reported antagonistic activity at serotonin receptor systems in neuropharmacology models, supporting its relevance to studies of adrenergic and serotonergic network integration. Based on available evidence, its primary targets include beta1 and beta2 adrenergic receptors, and it has also been described as interacting with 5 HT receptor subtypes with binding activity observed in the nanomolar range in selected hippocampal preparations, making it suitable for mechanistic experiments that examine receptor blockade dependent modulation of cyclic AMP linked signaling, downstream protein kinase pathways, neuronal excitability, and cardiovascular response phenotypes in controlled laboratory settings. In vitro characterization is generally consistent with potent receptor level activity from nanomolar to micromolar concentration ranges depending on assay format, species background, and endpoint selection, while in vivo and ex vivo use has been reported in standard preclinical paradigms for autonomic regulation, hemodynamic pharmacology, and central nervous system receptor function; in practical screening workflows, it is typically positioned as a reference antagonist or comparator compound for target validation, pathway deconvolution, and profiling of candidate molecules with beta adrenergic or mixed receptor pharmacology, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.